GUÍAS ALAD People with Type 2 diabetes now have personalized treatment options Genetic factors tied to obesity may protect against diabetes. OPS. Guias ALAD de diagnostico, control y tratamiento de la Diabetes Mellitus Tipo 2, (In Spanish) Veracruz Initiative for Diabetes Awareness, Barcelo A, Jawed M, Qiang A. PAHO Diabetes Guideline Project Group. .. Guías ALAD sobre el diagnóstico, control y tratamiento de la diabetes .. Guía clínica de diabetes tipo 2. Santiago: MINSAL;. Available from:
|Published (Last):||23 April 2008|
|PDF File Size:||2.8 Mb|
|ePub File Size:||13.55 Mb|
|Price:||Free* [*Free Regsitration Required]|
Efect of glucagon-like peptide-1 proglucagon amide on hepatic glucose production in healthy man. Primera Encuesta Nacional de Factores de Riesgo.
Revista de la Sociedad Argentina de Diabetes ; Cusi K, De Fronzo R. Ala J Clin Nutr doi: Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: In the late s both WHO and the NAtional Diabetes Data Group produced new diagnostic criteria and a new classification system for diabetes mellitus.
Diabetes Metab Res Rev ; Systematic review of herbs and dietary supplements for glycemic idabetes in diabetes. J Hum Hypertens ; A week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes. Effect of dietary energy restriction on glucose production and substrate utilization in type 2 diabetes.
Over the past decade it has been obvious that the prevalence of type 2 diabetes is increasing rapidly. Diabetes Obes Metab ; Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control.
American Diabetes Association®
Diabetes Metab Syndr Obes ; 6: Finding new treatments for diabetes: Beneficial effect on diavetes lipid levels from energy restriction and fat loss in obese individuals with or without type 2 diabetes. Diiabetes we still need pioglitazone for the treatment of type 2 diabetes? The goal of the U. SGLT-2 inhibitors and cardiovascular risk: Am J Clin Nutr The Finnish Diabetes Prevention Study. Genital and urinary tract infections in diabetes: Curr Med Res Opinion Herman W, et al. Sodium-glucose cotransporter-2 inhibition and the potential for renal protection in diabetic nephropathy.
Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. No authors listed, Diabetes Prevention Program Group.
Diabetes: Scientific and Technical Material
Valensi P, et al. Promoting weight loss in type II diabetes. Dose response relation between sulfonylureas drugs and mortality in type 2 diabetes. Most developing countries of Latin America are in a stage of epidemiologic transition, which is the transition from infectious to chronic diseases as major sources of morbidity and mortality. Saxagliptin and cardiovascular outcomes diabehes patients with type 2 diabetes mellitus.
New Engl J Med Egan A, Blind Guiias, et al. Population and Individual Approach to the Prevention and Management of Diabetes and Obesity, Obesity and diabetes are affecting the peoples of the Americas at high and increasing rates. Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: Ann Intern Med A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors.
This document was prepared with input from a group of experts and people with diabetes from 25 countries of the Americas with the aim of providing a simple framework for diabetes care.